16 results on '"Rai, Shivam"'
Search Results
2. The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN
3. IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells
4. Stage-wise green supply chain management and environmental performance: Impact of blockchain technology
5. Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms
6. Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm
7. Organizational resilience and social-economic sustainability: COVID-19 perspective
8. JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms
9. Hospitality branding in emerging economies: an Indian perspective
10. Tracking of epigenetic changes during hematopoietic differentiation of induced pluripotent stem cells
11. MPN patients with low mutant JAK2 allele burden show late expansion restricted to erythroid and megakaryocytic lineages
12. The Second Generation Type II JAK2 Inhibitor, AJ1-10502, Demonstrates Enhanced Selectivity, Improved Therapeutic Efficacy and Reduced Mutant Cell Fraction Compared to Type I JAK2 Inhibitors in Models of Myeloproliferative Neoplasms (MPNs)
13. Combination of 5-Azacytidine and Pegifna Is Able to Overcome Resistance in JAK2-V617F Positive MPN with Loss of Dnmt3a
14. Inhibiting Glutamine Metabolism with CB-839 Reduces Erythrocytosis in MPN Mice
15. Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms.
16. Evaluation of DNA damage in Type 2 diabetes mellitus patients with and without peripheral neuropathy: A study in South Indian population.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.